Europe Blood Collection Devices Market Forecast to 2030 - Regional Analysis - by Product, Methods, and End User

The Europe blood collection devices market is expected to grow from US$ 2.40 billion in 2022 to US$ 3.82 billion by 2030. It is estimated to grow at a CAGR of 6.0% from 2022 to 2030.

Surge in Demand for Minimally Invasive Diagnostic Tests Drives Europe Blood Collection Devices Market

Minimally invasive sampling techniques, such as capillary blood sampling, are routinely used for point-of-care testing in the home healthcare setting and clinical settings, such as the ICU, providing less pain and wounding than conventional venipuncture. There is a growing preference for minimally or non-invasive tests among patients for diagnostic purposes. Early cancer detection, tumor monitoring throughout treatment, mutation detection, and recurrence monitoring are possible using liquid biopsy and capillary blood sampling, which uses a non-invasive blood sample. Researchers can trace all genetic changes and epigenetics in solid tumors with a blood test, which is a simple and non-invasive technique. Patients select minimally invasive procedures for the advanced instruments used in the procedures, which allow for more complex and delicate work to be executed with less pain, lower risk, and less scarring.

Due to the advancements in technology in terms of feasibility and processing times, the blood collection procedure has recently attracted considerable interest as a non-invasive alternative. A blood test is a painless and non-invasive procedure that also reduces the cost and time it takes to diagnose a problem. A blood test is a simple alternative to surgical biopsies that allows doctors to discover information about tumors from a simple blood sample. Hence, the surge in demand for minimally invasive or non-invasive diagnostic tests fuels the Europe blood collection devices market growth.

Europe Blood Collection Devices Market Overview

The Europe blood collection devices market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany and France contribute significantly to the market in this region. The presence of prominent players and the prevalence of cardiovascular disease are the key factors driving the growth of the Europe blood collection devices market.

Europe Blood Collection Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Blood Collection Devices Market Segmentation

The Europe blood collection devices market is segmented into product type, methods, end user, and country.

Based on product type, the Europe blood collection devices Market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held the largest share of the Europe blood collection devices market in 2022.

In terms of methods, the Europe blood collection devices Market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held a larger share of the Europe blood collection devices market in 2022.

By end users, the Europe blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held the largest share of the Europe blood collection devices market in 2022.

Based on country, the Europe blood collection devices market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated Europe blood collection devices market in 2022.

Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, Greiner Bio One International GmBH, FL Medical SRL, and IntervacTechnology are some of the leading companies operating in the Europe blood collection devices market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe blood collection devices market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Europe blood collection devices market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the blood collection devices market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.